What is Novavax's other noncash income (expense)?

Novavax (NVAX) reported other noncash income (expense) of $8.97M in Q1 2026.

How has Novavax's other noncash income (expense) changed year-over-year?

Novavax's other noncash income (expense) increased by 154.2% year-over-year, from -$16.55M to $8.97M.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

Novavax NVAX Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Viridian Therapeutics, Inc.VRDN

-$169K-2,917%

ModernaMRNA

——

Roivant SciencesROIV

——

Merck & Co.MRK

——

Gilead SciencesGILD

——

ImmunityBio, Inc.IBRX

——

Other financials

Income statement

See full

Revenue$139.5M-79.1%

Gross profit$108.8M-83.3%

Operating income-$15.4M-103%

Net income-$9.5M-102%

EPS (diluted)-$0.06-102%

Balance sheet

See full

Cash & equivalents$228.4M-13.3%

Total debt$295.1M+404%

Total equity-$144.8M-91.4%

Total assets$1.0B-19.3%

Cash flow

See full

Operating cash flow-$32.4M+82.5%

CapEx$1.3M-20.4%

Free cash flow-$33.7M+82.0%

Valuation

See full

Market cap$1.46B+41.0%

Enterprise value$1.53B+83.6%

P/S2.5×+1.6×

Profitability

See full

Gross margin85%-2.5pp

Operating margin-13.1%-45.9pp

Net margin-14.7%-52.9pp

FCF margin-58.9%-61.4pp

Returns & leverage

See full

Return on equity-238.6%—

Debt / equity1.5×—

Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Novavax's other noncash income (expense)?: Novavax (NVAX) reported other noncash income (expense) of $8.97M in Q1 2026.
How has Novavax's other noncash income (expense) changed year-over-year?: Novavax's other noncash income (expense) increased by 154.2% year-over-year, from -$16.55M to $8.97M.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.